Oncology
Non-Hodgkin’s lymphoma
Lecturer | Narjess Ayati MD, IBNM, FEBNM, ABNC, FANMB |
---|---|
Objectives | Overall objectives On successful completion of this activity, participant should have an overview of Non-Hodgkin’s lymphoma (NHL), and the role of FDG-PET/CT in patient management. Specific objectives Following completion of this activity, the participant will achieve a brief knowledge about Non-Hodgkin’s lymphoma including: Epidemiology & Risk factors Prognosis and prognostic factors Clinical presentation Classification Initial diagnosis & staging Patient management Role of FDG PET/CT in NHL Response assessment criteria (including Deauville 5-point scoring system) |
Video | 16min |
Subtitle
Lecturer
Narjess Ayati, MD, IBNM, FEBNM, ABNC, FANMB
Department of Molecular Imaging and Therapy
Austin Health, Melbourne, Australia
E-mail:n_ayati@yahoo.com
Austin Health, Melbourne, Australia
E-mail:n_ayati@yahoo.com
Sze Ting LEE, MBBS, PhD, FRACP, FAANMS, Associate Professor
Department of Molecular Imaging & Therapy,
Austin Health, Victoria, Australia
E-mail:sze.ting.lee@bigpond.com
Austin Health, Victoria, Australia
E-mail:sze.ting.lee@bigpond.com